226 related articles for article (PubMed ID: 10822413)
1. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
Mansoor GA; Massie BM
Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.
Bombelli M; Facchetti R; Carugo S; Madotto F; Arenare F; Quarti-Trevano F; Capra A; Giannattasio C; Dell'Oro R; Grassi G; Sega R; Mancia G
J Hypertens; 2009 Dec; 27(12):2458-64. PubMed ID: 19654559
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy and heart failure in women.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
6. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
Opadijo OG; Omotoso AB; Akande AA
Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
[TBL] [Abstract][Full Text] [Related]
7. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
[TBL] [Abstract][Full Text] [Related]
8. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
[TBL] [Abstract][Full Text] [Related]
9. [Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension].
Cao Y; Zhao SP; Luo L
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):379-81. PubMed ID: 14653122
[TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
11. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
12. Can good surrogate end-points predict the prognosis of hypertensive patients?
Mancia G; Lanfranchi A; Turri C; Grassi G
J Hypertens Suppl; 1998 Oct; 16(5):S3-7. PubMed ID: 9868998
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathology of left ventricular hypertrophy].
Waeber B; Weber R; Brunner HR
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():9-14. PubMed ID: 7646313
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ambulatory blood pressure measurements: further analyses.
Perloff D; Sokolow M; Cowan RM; Juster RP
J Hypertens Suppl; 1989 May; 7(3):S3-10. PubMed ID: 2527294
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
17. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
Verdecchia P; Angeli F; Cavallini C; Mazzotta G; Repaci S; Pede S; Borgioni C; Gentile G; Reboldi G
J Hypertens; 2009 Aug; 27(8):1697-704. PubMed ID: 19424088
[TBL] [Abstract][Full Text] [Related]
18. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
Amabile G
Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
[TBL] [Abstract][Full Text] [Related]
19. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
20. Cardiac hypertrophy and hypertension.
Dunn FG
Blood Press Suppl; 1995; 2():17-21. PubMed ID: 7582068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
